Abstract
Aspergillus spp. are leading causes of morbidity and mortality in immunocompromised patients. This review provides an overview of host defenses, the mechanisms by which the alveolar-capillary barrier is breeched by Aspergillus, and the implications for diagnosis and treatment of patients with invasive pulmonary aspergillosis.
MeSH terms
-
Aspergillus / growth & development*
-
Aspergillus / immunology*
-
Humans
-
Immunocompromised Host*
-
Invasive Pulmonary Aspergillosis / drug therapy
-
Invasive Pulmonary Aspergillosis / immunology
-
Invasive Pulmonary Aspergillosis / microbiology*
-
Invasive Pulmonary Aspergillosis / pathology*
-
Lung / immunology
-
Lung / microbiology
-
Lung / pathology